Barclays lowered the firm’s price target on MetLife (MET) to $95 from $96 and keeps an Overweight rating on the shares following the Q4 report.
In a report released today, Alex Scott from Barclays maintained a Buy rating on Metlife (MET – Research Report), with a price target of $95.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback